About MarketWire
Investment Glossary
Investment Tools & Calculators
Advertise with Us
Work With Us
Contact us

Categories

Asian Markets
Australian Markets
Bonds & Fixed Income
Commodities
Economic Outlook & Trends
European Markets
Featured
Fixed Term Deposits
Forex
Global Markets
IPO & M&A News
Local news
Market Reports & Analysis
Stocks & Equities
U.S. Markets

Subscribe

Global Markets
Australian Markets
U.S. Markets
European Markets
Asian Markets
Featured

About MarketWire
Investment Glossary
Investment Tools & Calculators
Advertise with Us
Work With Us
Contact us

Editorial Policy
Cookie Policy
Disclaimer
About MarketWire
Contact us
Terms & Conditions

Bonds & Fixed Income
Fixed Term Deposits
Commodities
Forex
IPO & M&A News
Economic Outlook & Trends
Market Reports & Analysis

drug

1 post

© Reuters.

© Reuters.

Stocks & Equities

Eli Lilly stock dips on Novo Nordisk’s rival drug | Stock News

byMarketWire Editorial Team

January 24, 2025

Search

Latest News

Liz Kendall in sick pay update for 1.3 million | European Markets
America’s home affordability crisis has a simple | Global Market News
NSW Government taking action on waste crisis | Australian Markets
T-Mobile US Stock: Is TMUS Outperforming the | U.S. Markets
Best savings accounts and Cash ISAs for March | European Markets

Australian News

NSW Government taking action on waste crisis | Australian Markets
Minns Government sets high expectations for | Australian Markets
NSW Government launches local council grants to | Australian Markets
Reach drilling confirms gold model in WA’s | Australian Markets
Warren Buffett calls Trump’s tariffs a tax on | Australian Markets

Market Insights

Featured
A Bullish 2025 for the IPO Market? ETFs to | U.S. Markets
by MarketWire Editorial Team
February 27, 2025
Australian Markets
RBA reckons Australia’s economy is much smaller | Australian Markets
by MarketWire Editorial Team
February 27, 2025
Featured
Is Alphabet Stock Outperforming the Dow? | U.S. Markets
by MarketWire Editorial Team
February 27, 2025
Australian Markets
The Good, the Bad, and the Bubble | Australian Markets
by MarketWire Editorial Team
January 29, 2025

Markets
Investing News
Resources & Insights
Company

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use

Disclaimer:
The information provided on MarketWire.com.au is for general informational purposes only and does not constitute financial, investment, tax, or legal advice. While we strive to ensure the accuracy and timeliness of our content, MarketWire.com.au, its affiliates, and contributors make no guarantees regarding the completeness, reliability, or suitability of the information for your specific investment needs. All investments involve risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are encouraged to conduct their own research and seek professional advice from a licensed financial advisor before making any investment decisions. MarketWire.com.au may feature sponsored content, affiliate links, and advertisements, which do not constitute an endorsement of any products, services, or financial instruments. We maintain editorial independence and transparency in our reporting. By using this website, you acknowledge and agree to our Terms & Conditions, Privacy Policy, and Disclaimer.

© 2025 Marketwire.com.au All Rights Reserved.

Editorial Policy
Cookie Policy
Disclaimer
About MarketWire
Contact us
Terms & Conditions